Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYST

Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic...

Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic...
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , United States , Chinese , Bristol Myers Squibb , Rafaelg Amado , World Health Organization , National Medical Products Association , Regulatory Agency , Zai Lab Limited , Exchange Commission , European Commission , Head Of Global Oncology Research , Zai Lab , Zai Lab Forward , Trial Evaluating , Meets Primary Endpoint , Progression Free Survival , Mutated Locally Advanced , Metastatic Non Small Cell Lung , Lab Limited , Blinded Independent Central Review , Global Oncology Research , Myers Squibb , New Drug Application , Prescription Drug User Fee Act , Private Securities Litigation Reform Act ,